These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36353409)

  • 1. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients.
    Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A
    Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in
    Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania.
    Arbune M; Gurau G; Niculet E; Iancu AV; Lupasteanu G; Fotea S; Vasile MC; Tatu AL
    Infect Drug Resist; 2021; 14():2369-2378. PubMed ID: 34194233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESKAPE Pathogens: Antimicrobial Resistance Patterns, Risk Factors, and Outcomes a Retrospective Cross-Sectional Study of Hospitalized Patients in Palestine.
    Abukhalil AD; Barakat SA; Mansour A; Al-Shami N; Naseef H
    Infect Drug Resist; 2024; 17():3813-3823. PubMed ID: 39247758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
    Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
    Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ESKAPE Pathogens on Bacteremia: A Three-Year Surveillance Study at a Major Hospital in Southern Italy.
    De Prisco M; Manente R; Santella B; Serretiello E; Dell'Annunziata F; Santoro E; Bernardi FF; D'Amore C; Perrella A; Pagliano P; Boccia G; Franci G; Folliero V
    Antibiotics (Basel); 2024 Sep; 13(9):. PubMed ID: 39335074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital.
    Flores-Paredes W; Luque N; Albornoz R; Rojas N; Espinoza M; Pons MJ; Ruiz J
    Infect Chemother; 2021 Sep; 53(3):449-462. PubMed ID: 34508324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.
    Zhen X; Lundborg CS; Sun X; Hu X; Dong H
    Antimicrob Resist Infect Control; 2019; 8():137. PubMed ID: 31417673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health.
    Denissen J; Reyneke B; Waso-Reyneke M; Havenga B; Barnard T; Khan S; Khan W
    Int J Hyg Environ Health; 2022 Jul; 244():114006. PubMed ID: 35841823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary.
    Orosz L; Lengyel G; Ánosi N; Lakatos L; Burián K
    Acta Microbiol Immunol Hung; 2022 Jan; ():. PubMed ID: 35084364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and Carbapenem Susceptibility of Gram-Negative ESKAPE Pathogens in Hospitalized Patients from Three General Hospitals.
    Zhong S; He S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
    El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistome-based surveillance identifies ESKAPE pathogens as the predominant gram-negative organisms circulating in veterinary hospitals.
    Zendri F; Isgren CM; Devaney J; Schmidt V; Rankin R; Timofte D
    Front Microbiol; 2023; 14():1252216. PubMed ID: 37744932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
    Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.
    Artini M; Papa R; Vrenna G; Trecca M; Paris I; D'Angelo C; Tutino ML; Parrilli E; Selan L
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gram-Negative ESKAPE Bacteria Surveillance in COVID-19 Pandemic Exposes High-Risk Sequence Types of
    Cureño-Díaz MA; Plascencia-Nieto ES; Loyola-Cruz MÁ; Cruz-Cruz C; Nolasco-Rojas AE; Durán-Manuel EM; Ibáñez-Cervantes G; Gómez-Zamora E; Tamayo-Ordóñez MC; Tamayo-Ordóñez YJ; Calzada-Mendoza CC; Bello-López JM
    Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.